World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
11388
World Ranking
3446
National Ranking
1360

David M. Markovitz publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David M. Markovitz sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 144 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David M. Markovitz D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Markovitz sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 58 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

David M. Markovitz is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple disciplines, principally in the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. The subfields of study where they have contributed include Molecular Biology, Immunology, Oncology, Infectious Diseases, and Epidemiology.

Their work frequently addresses topics such as CAR-T cell therapy research, Glycosylation and Glycoproteins Research, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, and RNA regulation and disease.

David M. Markovitz has contributed to a range of recent publications, including:

  • A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo, 2020, Proceedings of the National Academy of Sciences
  • The role of the histone H3 variant CENPA in prostate cancer, 2020, Journal of Biological Chemistry
  • Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection, 2021, Frontiers in Immunology
  • A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo, 2022, Cell Reports Medicine
  • Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma, 2023, Journal for ImmunoTherapy of Cancer

Frequent co-authors collaborating with David M. Markovitz include:

  • Maureen Legendre (11 publications)
  • Evelyn Covés-Datson (4 publications)
  • Challice L. Bonifant (4 publications)
  • Malcolm K. Brenner (4 publications)
  • Johannes Stadlmann (4 publications)

Their research has been published frequently in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory) - 4 publications
  • Blood - 3 publications
  • Frontiers in Immunology - 2 publications
  • Nature Communications - 2 publications
  • Scientific Reports - 2 publications

David M. Markovitz has been recognized as a member of the Association of American Physicians. Their research contributions cover a broad range of biological and medical topics, with a focus on molecular and immune mechanisms relevant to cancer, infectious diseases, and therapeutic interventions.

Best Publications

  • The role of mononuclear phagocytes in HTLV-III/LAV infection

    Suzanne Gartner;Paul Markovits;David M. Markovitz;Mark H. Kaplan

  • Vimentin is secreted by activated macrophages.

    Nirit Mor-Vaknin;Antonello Punturieri;Antonello Punturieri;Kajal Sitwala;David M. Markovitz

  • Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

    Suzanne Gartner;Paul Markovits;David M. Markovitz;Robert F. Betts

  • The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.

    Paola Bargagna-Mohan;Adel Hamza;Yang-eon Kim;Yik Khuan Abby Ho

  • Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble

    Andrew C Stelzer;Aaron T Frank;Jeremy D Kratz;Michael D Swanson

  • A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication

    Michael D. Swanson;Harry C. Winter;Irwin J. Goldstein;David M. Markovitz

  • Human Endogenous Retrovirus K (HML-2) Elements in the Plasma of People with Lymphoma and Breast Cancer

    Rafael Contreras-Galindo;Mark H. Kaplan;Philippe Leissner;Thibault Verjat

  • TNF-α Inhibits HIV-1 Replication in Peripheral Blood Monocytes and Alveolar Macrophages by Inducing the Production of RANTES and Decreasing C-C Chemokine Receptor 5 (CCR5) Expression

    Brian R. Lane;David M. Markovitz;Nina L. Woodford;Rosemary Rochford

  • Interleukin-8 Stimulates Human Immunodeficiency Virus Type 1 Replication and Is a Potential New Target for Antiretroviral Therapy

    Brian R. Lane;Karin Lore;Paul J. Bock;Jan Andersson

  • An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.

    Shannon Kenney;James Kamine;David Markovitz;Randy Fenrick

  • Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene

    Michael S. Khodadoust;Monique Verhaegen;Ferdinand Kappes;Erica Riveiro-Falkenbach

  • The C-X-C chemokine IP-10 stimulates HIV-1 replication.

    Brian R Lane;Steven R King;Paul J Bock;Robert M Strieter

  • The Endothelial Cell-Specific Antibody PAL-E Identifies a Secreted Form of Vimentin in the Blood Vasculature

    Bin Xu;Robert M. deWaal;Nirit Mor-Vaknin;Chris Hibbard

  • A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.

    Jeffrey M. Leiden;Chung Yih Wang;Bronislawa Petryniak;David M. Markovitz

  • NGSQC: cross-platform quality analysis pipeline for deep sequencing data

    Manhong Dai;Robert C Thompson;Christopher Maher;Rafael Contreras-Galindo

  • The human LON protease binds to mitochondrial promoters in a single-stranded, site-specific, strand-specific manner.

    Glenn K. Fu;David M. Markovitz

  • DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress

    F. Kappes;J. Fahrer;M. S. Khodadoust;A. Tabbert

  • Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates.

    Anna U. Bielinska;Katarzyna W. Janczak;Jeffrey J. Landers;David M. Markovitz

  • Expression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1

    Marta J. Gonzalez-Hernandez;Michael D. Swanson;Rafael Contreras-Galindo;Sarah Cookinham

  • Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity

    Michael D. Swanson;Michael D. Swanson;Daniel M. Boudreaux;Loïc Salmon;Jeetender Chugh

  • Infection with the human immunodeficiency virus type 2.

    David M. Markovitz

Frequent Co-Authors

Robert M. Strieter
Robert M. Strieter University of Virginia
Hal E. Broxmeyer
Hal E. Broxmeyer Indiana University
Mark H. Kaplan
Mark H. Kaplan Indiana University
Arul M. Chinnaiyan
Arul M. Chinnaiyan University of Michigan–Ann Arbor
Scott Cooper
Scott Cooper Indiana University
Gilbert S. Omenn
Gilbert S. Omenn University of Michigan–Ann Arbor
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Irwin J. Goldstein
Irwin J. Goldstein University of Michigan–Ann Arbor
Maureen A. Sartor
Maureen A. Sartor University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various healthcare and medical careers beyond traditional laboratory roles. For those interested in holistic patient care, becoming a functional medicine nurse offers a specialized path combining microbiology knowledge with patient-focused treatment strategies.

Alternatively, graduates can explore the administrative side of healthcare through roles like Certified Professional Coders. Understanding medical coding is critical for healthcare operations, and information about certified professional coder salary and career paths highlights the strong demand and earning potential in this field.

For those interested in managing medical data and healthcare systems, pursuing a degree in Health Information Management is a smart choice. Insights on health information management salary entry-level roles show promising job growth and stability in healthcare administration.

To get started on this path, students should consider enrolling in the best online health information management degree cahiim accredited programs, which offer flexible learning options and industry-recognized credentials.

Best Scientists Citing David M. Markovitz

Trending Scientists